Tag: Genomic
Genomic Vision announces the drawing of the first tranche of €2 million under the financing program concluded with Winance for a maximum amount of €30 million – 09/06/2022 at 6:00 p.m.
Bagneux (France) – Genomic Vision (FR0011799907 – GV, PEA-PME eligible), a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications (the “Company”), announces…
A 50% rebound in one week for Genomic, what now?
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
Genomic Vision: changes in governance – 2022-07-13 at 18:00
Bagneux (France) – GENOMIC VISION (FR0011799907 – GV, PEA-PME eligible), a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, today announces changes…
Genomic Vision announces the approval by its AGM of all the resolutions supported by the Management Board – 05/23/2022 at 7:00 p.m.
The EGM adopted all of the proposed resolutions, with the exception of the 21st resolution which was rejected in accordance with the recommendations of the Management Board. The meeting notably…
Genomic Vision: new line of financing with Winance
(Boursier.com) — Genomic Vision, a biotechnology company that develops tools and services dedicated to the analysis and control of genome modifications, announces today the establishment of a new line of…
Genomic Vision: sells technologies to a US university – 02/17/2022 at 18:29
(CercleFinance.com) – Genomic Vision announces that its technology has been adopted by the Department of Cellular and Molecular Biology at the University of Florida to study the mechanisms of DNA…
Genomic Vision: sells technologies to a US university
(CercleFinance.com) – Genomic Vision announces that its technology has been adopted by the Department of Cellular and Molecular Biology at the University of Florida to study the mechanisms of DNA…
Agendia partners with Illumina to develop genomic testing for breast cancer treatment
A multi-year partnership to advance the use of next-generation sequencing of decentralized oncology tests to bring better knowledge to breast cancer patients worldwide. Agendia, Inc., a commercialization-phase company focused on…
Genomic Vision: drawdown of two tranches of bonds, for 2 ME
Through Alexandra Saintpierre Posted on 12/27/2021 at 6:14 a.m. Photo credit © Genomic Vision / Agnès Janin (Boursier.com) – The biotechnology company Genomic Vision, which develops tools and services dedicated…
To be continued today … Genomic Vision
(AOF) – Genomic Vision announced on Friday the issue of the 5th and 6th tranche of bonds convertible into shares with share subscription warrants (OCABSA) for an amount of 2…
Genomic Vision: issuance of two tranches of OCABSA
(CercleFinance.com) – Genomic Vision announces the issue of the fifth and sixth tranches of bonds convertible into shares with BSA (OCABSA) for two million euros, within the framework of the…
Genomic Vision: issuance of two installments of OCABSA – 12/27/2021 at 08:02
(CercleFinance.com) – Genomic Vision announces the issue of the fifth and sixth tranches of bonds convertible into shares with BSA (OCABSA) for two million euros, within the framework of the…